Holen Sie sich die Stockscreener-App
169.97
2.07%
3.5841
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
Jazz Pharmaceuticals plc to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex®? (Cannabidiol) Outcomes in Treatment-Resistant Epilepsies At the American Epilepsy Society 2025 Annual Meeting - marketscreener.com
Jazz Pharmaceuticals to present new Epidiolex data at epilepsy meeting By Investing.com - Investing.com UK
Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American Epilepsy Society 2025 Annual Meeting - PR Newswire
Saturn V Capital Management LP Buys New Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Trials, Sales Wins Sends Jazz Pharmaceuticals Higher - FXEmpire
Will Jazz Pharmaceuticals plc stock pay special dividendsEarnings Beat & High Conviction Buy Zone Picks - Newser
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Systematic Financial Management LP - MarketBeat
Is Jazz Pharmaceuticals plc (J7Z) stock attractive for growth fundsEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
Why hedge funds are buying Jazz Pharmaceuticals plc stock2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - Newser
What MACD trends signal for Jazz Pharmaceuticals plc (J7Z) stockPortfolio Profit Report & Expert Verified Movement Alerts - Newser
How Jazz Pharmaceuticals plc (J7Z) stock performs in easing cyclesShort Setup & Weekly Market Pulse Updates - Newser
Mackenzie Financial Corp Raises Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by Prudential Financial Inc. - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Distillate Capital Partners LLC - MarketBeat
Will Jazz Pharmaceuticals plc (J7Z) stock benefit from infrastructure billQuarterly Performance Summary & Fast Moving Market Watchlists - Newser
Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksQuarterly Risk Review & Expert Verified Movement Alerts - Newser
Why Jazz Pharmaceuticals plc (J7Z) stock appeals to dividend investorsPrice Action & AI Driven Stock Movement Reports - Newser
Does Jazz Pharmaceutical's Acquisition of Gentium S.p.A. Signal Investment Upside? - AOL.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) Director Sells $13,780,275.00 in Stock - MarketBeat
Jazz to present pivotal phase 3 results for Ziihera in GEA at ASCO GI - Investing.com Canada
Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCO Gastrointestinal Cancers Symposium - PR Newswire
Looking Into Jazz Pharmaceuticals PLC's Recent Short Interest - Benzinga
Capital Fund Management S.A. Takes $4.27 Million Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Loomis Sayles & Co. L P Trims Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Is Jazz Pharmaceuticals plc stock attractive for retirement portfoliosJuly 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Why Jazz Pharmaceuticals plc (J7Z) stock remains stableJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Jazz Pharmaceuticals Insider Sold Shares Worth $13,780,337, According to a Recent SEC Filing - marketscreener.com
Jazz Pharmaceuticals PLC $JAZZ Stake Boosted by Vinva Investment Management Ltd - MarketBeat
American Century Companies Inc. Has $26.85 Million Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Legal & General Group Plc Purchases 18,675 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
SG Americas Securities LLC Has $377,000 Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by Measured Wealth Private Client Group LLC - MarketBeat
Insomnia Therapeutics Market is Going to Boom: Strategic - openPR.com
Jazz Pharmaceuticals PLC $JAZZ Shares Acquired by Ensign Peak Advisors Inc - MarketBeat
A Look at Jazz Pharmaceuticals’s Valuation After Breakthrough Phase 3 Ziihera Trial Results - Yahoo Finance
JPMorgan Chase & Co. Purchases 59,252 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Dynamic Technology Lab Private Ltd Sells 2,945 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Rhenman & Partners Asset Management AB - MarketBeat
The Bull Case For Jazz Pharmaceuticals (JAZZ) Could Change Following Breakthrough Phase 3 Ziihera Trial Results - simplywall.st
Why Jazz Pharmaceuticals May Be a Stealth Cannabis Winner - Yahoo Finance
Jazz Pharma director McSharry sells $607k in shares By Investing.com - Investing.com Australia
Jazz Pharma director McSharry sells $607k in shares - Investing.com
Jazz Pharmaceuticals Insider Sold Shares Worth $607,127, According to a Recent SEC Filing - MarketScreener
Jazz Gains From Ziihera Data, Upside Seen as Priced In, UBS Says - MarketScreener
JAZZ Downgraded to Neutral by UBS, Price Target Raised to $188 | - GuruFocus
UBS Downgrades Jazz Pharmaceuticals to Neutral From Buy, Raises Price Target to $188 From $163 - MarketScreener
Jazz Pharmaceuticals stock downgraded by UBS despite price target increase - Investing.com Nigeria
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.
A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results - simplywall.st
JAZZJazz Pharmaceuticals plc Stock Price and Quote - Finviz
How strong is Jazz Pharmaceuticals plc stock balance sheetJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Jazz Pharmaceuticals Insider Sold Shares Worth $3,259,538, According to a Recent SEC Filing - MarketScreener
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock By Investing.com - Investing.com South Africa
0.82%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):